China Universal Asset Management Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Buy |
|
|||||
|
2025
Q1 | $2.73M | Sell |
|
|||||
|
2024
Q4 | $2.68M | Buy |
|
|||||
|
2024
Q3 | $2.6M | Buy |
|
|||||
|
2024
Q2 | $1.87M | Sell |
|
|||||
|
2024
Q1 | $3.2M | Buy |
|
|||||
|
2023
Q4 | $2.14M | Buy |
|
|||||
|
2023
Q3 | $786K | Buy |
|
|||||
|
2023
Q2 | $565K | Sell |
|
|||||
|
2023
Q1 | $640K | Sell |
|
|||||
|
2022
Q4 | $2.68M | Sell |
|
|||||
|
2022
Q3 | $2.53M | Buy |
|
|||||
|
2022
Q2 | $2.33M | Buy |
|
|||||
|
2022
Q1 | $529K | Buy |
|